NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,803.20+₹42.20 (+2.4%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
Loading market information…
NSE · BROOKS.NS · INR
Stock price, earnings
Quote as of Oct 30, 2026, 08:07 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Brooks Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 46.41% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Brooks Laboratories Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Brooks Laboratories Limited is a pharmaceutical enterprise engaged in the contractual manufacturing and distribution of medicinal products. The company serves both the Indian domestic market and international clients. Its comprehensive product portfolio includes carbapenem medications, various tablets, dry syrups, both liquid and powdered injectable solutions, and specialized eye and ear drops. Brooks Laboratories Limited was established in 2002 and is headquartered in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,803.20+₹42.20 (+2.4%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
₹9,742.00+₹78.00 (+0.81%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
₹456.00-₹1.00 (-0.22%)
Bafna Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 4.99% below the high.
₹136.00-₹0.54 (-0.4%)
ZIM Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.9% below the high.
₹128.33₹0.00 (0.0%)
Valiant Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 9.23% below the high.
₹110.00-₹0.84 (-0.76%)
Aarey Drugs & Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 4.18% below the high.
₹10.18-₹0.15 (-1.45%)
Nectar Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 54.55% below the high.
₹10.88-₹0.18 (-1.63%)
TAKE Solutions Limited’s quoted price sits in the lower half of its reported 52-week range, 78.3% below the high.
